The increase in excitatory outflow from the medial prefrontal cortex is critical to the development of sensitization to amphetamine. There is evidence that psychostimulant-induced changes in dopamine-GABA interactions are key to understanding the behaviorally sensitized response. The objective of this study was to characterize the effects of different amphetamine paradigms on the Fos activation of GABAergic interneurons that contain parvalbumin in the medial prefrontal cortex. Although a sensitizing, repeated regimen of amphetamine induced Fos in all cortical layers, only layer V parvalbumin-immunolabeled cells were activated in the infralimbic and prelimbic cortices. Repeated amphetamine treatment was also associated with a loss of parvalbumin immunoreactivity in layer V, but only in the prelimbic cortex. An acute amphetamine injection to na茂ve rats was associated with an increase in Fos, but in parvalbumin-positive neurons of the prelimbic cortex, where it was preferentially induced in layer III. These data indicate that distinct substrates mediate the response to repeated or acute amphetamine treatment. They also suggest that a sensitizing amphetamine regimen directs mPFC outflow, via changes in inhibitory neuron activation, towards subcortical centers important in reward.Keywords prelimbic cortex; infralimbic cortex; GABA; dopamine; Fos; behavioral sensitization Repeated amphetamine (AMPH) exposure in humans has been associated with long-lasting changes in behavior (Robinson and Berridge, 2000). In experimental animals, such treatment progressively augments locomotion (behavioral sensitization), an effect that persists after treatment and can be measured by a drug challenge (Wolf, 1998). Sensitization to AMPH appears to require changes in dopamine and excitatory amino acid transmission in the medial prefrontal cortex (mPFC) and ventral tegmental area (VTA) (Wolf et al., 1995;Li and Wolf, 1997;Tzschentke and Schmidt, 2000;Wolf et al., 2003). Lesions of the mPFC block the development of sensitization, whether AMPH is repeatedly injected systemically or intra-VTA (Wolf et al., 1995;Li and Wolf, 1997;Cador et al., 1999; but see Tzschentke and Schmidt, 2000). AMPH sensitization also induces region-specific increases in mPFC Fos expression (Hedou et al., 2002), although the active neurons have yet to be fully identifed.Correspondence should be addressed to Maud M. Morshedi, Department of Cellular and Molecular Pharmacology, Chicago Medical School, Rosalind Franklin University of Medicine and Science, 3333 Green Bay Road, North Chicago, IL 60064, USA, (maud.morshedi@students.rosalindfranklin.edu). Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could ...